Literature DB >> 1788157

Iontophoretic delivery of a series of tripeptides across the skin in vitro.

P G Green1, R S Hinz, A Kim, F C Szoka, R H Guy.   

Abstract

The iontophoresis of eight tripeptides, of the general structure alanine-X-alanine, has been measured across hairless mouse skin in vitro. The peptides were blocked (a) at the carboxyl terminus using the mixed anhydride reaction with t-butylamine and (b) at the amino terminus by acetylation with 14C-acetic anhydride. The nature of the central residue (X) was varied by selecting one of five neutral amino acids, two negatively chargeable moieties (aspartic and glutamic acids), and a positively chargeable species (histidine). Constant current iontophoresis at 0.36 mA/cm2, using Ag/AgCl electrodes, was performed for 24 hr in diffusion cells, which allowed both anode and cathode to be situated on the same (epidermal) side of a single piece of skin. Due to a combination of osmotic and electroosmotic forces, the anodal iontophoretic flux of neutral peptides was significantly greater than passive transport. Steady-state fluxes were not achieved, however, suggesting that time-dependent changes in the properties of the skin barrier may be occurring. Limited, further experiments confirmed that, on a 24-hr time scale, these changes were not fully reversible. The cathodal delivery of anionic permeants was well controlled at a steady and highly enhanced rate by the current flow. This behavior closely paralleled earlier work using simple negatively charged amino acids and N-acetylated amino acid derivatives. It appears that the normalized iontophoretic flux of these anionic species is independent of lipophilicity but may be inversely related to molecular weight. The positively charged peptide, Ac-Ala-His-Ala-NH(But), showed greater anodal iontophoretic enhancement when delivered from a donor solution at pH 4.0 than from a solution at pH 7.4.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1788157     DOI: 10.1023/a:1015846100305

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

Review 1.  Direct current iontophoretic transdermal delivery of peptide and protein drugs.

Authors:  Y W Chien; O Siddiqui; W M Shi; P Lelawongs; J C Liu
Journal:  J Pharm Sci       Date:  1989-05       Impact factor: 3.534

2.  Transdermal delivery of human insulin to albino rabbits using electrical current.

Authors:  B R Meyer; H L Katzeff; J C Eschbach; J Trimmer; S B Zacharias; S Rosen; D Sibalis
Journal:  Am J Med Sci       Date:  1989-05       Impact factor: 2.378

3.  Characterization of the pore transport properties and tissue alteration of excised human skin during iontophoresis.

Authors:  R R Burnette; B Ongpipattanakul
Journal:  J Pharm Sci       Date:  1988-02       Impact factor: 3.534

4.  Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin.

Authors:  R R Burnette; D Marrero
Journal:  J Pharm Sci       Date:  1986-08       Impact factor: 3.534

5.  Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro.

Authors:  P G Green; R S Hinz; C Cullander; G Yamane; R H Guy
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

6.  Noninvasive sampling of biological fluids by iontophoresis.

Authors:  P Glikfeld; R S Hinz; R H Guy
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

7.  Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes.

Authors:  M J Pikal; S Shah
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

8.  Iontophoretic transport of a homologous series of ionized and nonionized model compounds: influence of hydrophobicity and mechanistic interpretation.

Authors:  S Del Terzo; C R Behl; R A Nash
Journal:  Pharm Res       Date:  1989-01       Impact factor: 4.200

Review 9.  Transdermal drug delivery: problems and possibilities.

Authors:  V M Knepp; J Hadgraft; R H Guy
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1987       Impact factor: 4.889

10.  Control of blood glucose levels in alloxan-diabetic rabbits by iontophoresis of insulin.

Authors:  B Kari
Journal:  Diabetes       Date:  1986-02       Impact factor: 9.461

View more
  20 in total

Review 1.  Optimisation of treatment by applying programmable rate-controlled drug delivery technology.

Authors:  Yie W Chien; Senshang Lin
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Sonophoresis. I. The use of high-frequency ultrasound to enhance transdermal drug delivery.

Authors:  D Bommannan; H Okuyama; P Stauffer; R H Guy
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

3.  Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH.

Authors:  R F Lopez; M V Bentley; M B Delgado-Charro; R H Guy
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

4.  Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro.

Authors:  P G Green; R S Hinz; C Cullander; G Yamane; R H Guy
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

5.  Theoretical design of prodrug-enhancer combination based on a skin diffusion model: prediction of permeation of acyclovir prodrugs treated with 1-geranylazacycloheptan-2-one.

Authors:  H Bando; T Takagi; F Yamashita; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

6.  Ionized prodrugs of dehydroepiandrosterone for transdermal iontophoretic delivery.

Authors:  S Laneri; A Sacchi; E A di Frassello; E Luraschi; P Colombo; P Santi
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

7.  Iontophoretic skin permeation of peptides: an investigation into the influence of molecular properties, iontophoretic conditions and formulation parameters.

Authors:  Gayathri Krishnan; Michael S Roberts; Jeffrey Grice; Yuri G Anissimov; Hamid R Moghimi; Heather A E Benson
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

Review 8.  Transfollicular drug delivery.

Authors:  A C Lauer; L M Lieb; C Ramachandran; G L Flynn; N D Weiner
Journal:  Pharm Res       Date:  1995-02       Impact factor: 4.200

Review 9.  Transdermal drug delivery of insulin with ultradeformable carriers.

Authors:  Gregor Cevc
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Iontophoresis of dexamethasone phosphate: competition with chloride ions.

Authors:  J-P Sylvestre; C Díaz-Marín; M B Delgado-Charro; R H Guy
Journal:  J Control Release       Date:  2008-07-06       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.